Chewing gum sets trap for SARS-CoV-2, reduces transmission

Jeremy Booth, Dental Tribune International

Wed. 22. December 2021

save

PHILADELPHIA, U.S.: A study led by researchers from University of Pennsylvania School of Dental Medicine has found that a chewing gum laced with angiotensin-converting enzyme 2 (ACE2) proteins debulks SARS-CoV-2 in the oral cavity. The gum, if proved safe and effective, could join masks and other physical barriers as an affordable tool that reduces the chance of transmission.

The study sought to advance the novel concept of debulking virus in the oral cavity using a chewing gum infused with clinical-grade ACE2 plant biomass. The research team grew the biomass in plants and paired it with another compound that enabled the protein to bind more effectively, and the biomass was incorporated into cinnamon-flavored gum tablets.

In a series of tests, the researchers found that the ACE2 protein neutralized SARS-CoV-2, that the gum largely prevented viral particles from entering cells and that viral RNA levels in SARS-CoV-2-infected saliva samples fell so substantially when exposed to the gum that they were close to being undetectable.

The study was led by Dr. Henry Daniell, W.D. Miller Professor in the Department of Basic and Translational Sciences in the University of Pennsylvania School of Dental Medicine. Dr. Daniell commented in the university publication Penn Today: “SARS-CoV-2 replicates in the salivary glands, and we know that when someone who is infected sneezes, coughs, or speaks some of that virus can be expelled and reach others.” He said that the chewing gum “offers an opportunity to neutralize the virus in the saliva, giving us a simple way to possibly cut down on a source of disease transmission.”

We are already using masks and other physical barriers to reduce the chance of transmission,” Dr. Daniell commented, adding: “This gum could be used as an additional tool in that fight.”

Co-author, Dr. Ronald Collman, professor of medicine at the University of Pennsylvania Perelman School of Medicine, commented that Dr. Daniell’s approach to making the plant protein for oral use was “inexpensive, hopefully scalable; it really is clever.”

The researchers are now seeking permission to evaluate the chewing gum in people infected with SARS-CoV-2, according to Penn Today.

Coincidentally, Dr. Daniell had already been conducting research projects that involved the ACE2 receptor protein and chewing gum before the pandemic. He had been studying the ACE2 protein in the context of treatment for hypertension—his laboratory having grown the protein—and working to develop a chewing gum infused with plant-grown proteins that would disrupt dental plaque.

The study, titled “Debulking SARS-CoV-2 in saliva using angiotensin converting enzyme 2 in chewing gum to decrease oral virus transmission and infection,” was published online on Nov. 10, 2021, in Molecular Therapy, ahead of inclusion in an issue.

Tags:

To post a reply please login or register

Scientists say SARS-CoV-2 is spreading through airborne transmission

GENEVA, Switzerland: When it comes to airborne pathogens, size matters. Scientists have written an open letter urging the World Health Organization (WHO) to...

Study reviews preventive SARS-CoV-2 transmission measures in Italy

PISA, Italy: According to the World Health Organization, Italy has 225,435 confirmed SARS-CoV-2 cases and 31,908 associated deaths as of 19 May 2020. This ...

Waterlase dental laser minimizes risk of SARS-CoV-2 transmission

IRVINE, Calif., U.S.: As dental offices are beginning to reopen, the American Dental Association has issued guidance recommending the reduction of aerosol ...

WHO calls for delay of non-urgent dental care in areas with high SARS-CoV-2 transmission

GENEVA, Switzerland: The World Health Organization (WHO) has warned that dental settings may pose an even greater risk for the spread of SARS-CoV-2 than was...

Saliva testing for SARS-CoV-2 takes off

LEIPZIG, Germany: Researchers in India have found that scientific literature supports salivary diagnostics for SARS-CoV-2 infection as an alternative to ...

Dentists join queue for SARS-CoV-2 vaccines

LEIPZIG, Germany: UK health authorities have administered the first doses of the SARS-CoV-2 vaccine developed by Pfizer and BioNTech, and public health ...

The mouth and SARS-CoV-2: Evidence of infected cells suggests key role in infection, transmission

BETHESDA, Md., U.S.: COVID-19 can cause a number of symptoms in the oral cavity, such as lesions, ulcerations and a loss of taste, and yet the role of the ...

EFP devises SARS-CoV-2 safety protocol for dental patients and practices

BRUSSELS, Belgium: The provision of oral healthcare services has been severely affected all over the world by the SARS-CoV-2 pandemic because of the risk of...

Organizations plead for SARS-CoV-2 testing kits in US dental clinics

WASHINGTON, U.S.: A consortium of U.S. dental organizations has asked for federal authorization for licensed dentists to conduct SARS-CoV-2 testing in their...

What we know about a SARS-CoV-2 vaccine so far

LEIPZIG, Germany: As the race to develop a SARS-CoV-2 vaccine continues, certain questions may arise that need clarification. While some still doubt the ...

Education

Live webinar
Tue. 23 September 2025
10:00 am EST (New York)